DOCSLIB.ORG

Pilocytic Astrocytomas

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pilocytic Astrocytomas AFIP ARCHIVES 1693 From the Archives of the AFIP Pilocytic Astrocytoma: Radiologic- Pathologic Correlation1 Kelly K. Koeller, CAPT, MC, USN ● Elisabeth J. Rushing, CME FEATURE RadioGraphics COL, MC, USA See accompanying test at http:// www.rsna.org /education Pilocytic astrocytoma is the most common pediatric central nervous /rg_cme.html system glial neoplasm and the most common pediatric cerebellar tu- mor. This tumor has a noteworthy benign biologic behavior that trans- LEARNING OBJECTIVES lates into an extremely high survival rate—94% at 10 years—that is by FOR TEST 6 far the best of any glial tumor. Most patients present in the first 2 de- After reading this cades, and clinical symptoms and signs are usually of several months article and taking the test, the reader duration and directly related to the specific location of the tumor. The will be able to: cerebellum, optic nerve and chiasm, and hypothalamic region are the Ⅲ Describe the salient most common locations, but the tumor can also be found in the cere- demographic and clinical features of bral hemisphere, ventricles, and spinal cord. Surgical resection is the pilocytic astrocy- treatment of choice for all tumors, except for those involving the optic toma. pathway and hypothalamic region, which may be treated with radiation Ⅲ Identify the charac- teristic imaging ap- therapy and chemotherapy. Cross-sectional imaging often demon- pearances of pilocytic strates a classic appearance: a cystic mass with an enhancing mural astrocytoma in chil- dren and adults, in- nodule. Less common appearances are quite nonspecific. Surrounding cluding the presence vasogenic edema is rarely present, and this feature provides a valuable of dissemination. Ⅲ Discuss the direct clue to the correct diagnosis. Accurate interpretation of imaging stud- correlation of the ies plays an essential role in directing treatment of these tumors, par- imaging appearances ticularly when they arise in the optic pathway of patients with neurofi- with the gross patho- logic and histologic bromatosis type 1. Disseminated disease and recurrence are extremely appearances in pilo- rare. cytic astrocytoma. Abbreviations: NF1 ϭ neurofibromatosis type 1, WHO ϭ World Health Organization Index terms: Astrocytoma, 10.3639 ● Brain neoplasms, 10.3639 ● Neoplasms, in infants and children, 10.3639 RadioGraphics 2004; 24:1693–1708 ● Published online 10.1148/rg.246045146 ● Content Codes: 1From the Departments of Radiologic Pathology (K.K.K.) and Neuropathology (E.J.R.), Armed Forces Institute of Pathology, 14th St at Alaska Ave, Bldg 54, Rm M-121, Washington, DC 20306-6000; Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, Bethesda, Md (K.K.K.); and Department of Pathology, George Washington University, Washington, DC (E.J.R.). Received July 19, 2004; revision requested August 20 and received September 7; accepted September 7. Both authors have no financial relationships to disclose. Address cor- respondence to K.K.K. (e-mail: koeller@afip.osd.mil). The opinions and assertions contained herein are the private views of the authors and are not to be construed as official nor as representing the views of the Departments of the Navy, Army, or Defense. 1694 November-December 2004 RG f Volume 24 ● Number 6 Introduction Most of the lesions occur in or near the midline, Originally identified in a series of 76 cases of cer- usually arising from the cerebellum, the optic ebellar astrocytomas by Harvey Cushing in 1931, nerve and chiasm, or the region of the hypothala- the pilocytic astrocytoma occupies a unique place mus-thalamus. Less common locations include among cerebral neoplasms (1). With its notable the cerebral hemispheres, the cerebral ventricles, indolent biologic behavior, pilocytic astrocytoma velum interpositum, and spinal cord (5–9). In carries one of the highest survival rates of any adults, the tumor more frequently occurs in the brain tumor and certainly the highest rate for any cerebral hemisphere (8,10). astrocytoma. Yet, as reviewed herein, there are The association of pilocytic astrocytoma with numerous oddities about this neoplasm. It appears neurofibromatosis type 1 (NF1) is well docu- well circumscribed, yet occasionally it infiltrates mented. Pilocytic astrocytoma is the most com- the surrounding brain tissue, as seen at histologic mon tumor seen in this population, occurring in RadioGraphics examination. It enhances intensely, sometimes up to 15%–21% of all NF1 patients, and typically with a ringlike pattern that is more commonly involves the optic nerve or chiasm (3,11–16). Be- seen in highly malignant astrocytomas, yet it is cause the vast majority of optic pathway gliomas not a high-grade neoplasm. In rare cases, it can are histologically regarded as pilocytic astrocy- even produce widespread dissemination, which toma, it has been suggested that the most appro- seems incongruous for a brain tumor with slow priate term for this entity should be “pilocytic growth and fairly bland histologic characteristics. astrocytoma of the optic pathway” (16). Nearly Even more fascinating, such metastatic spread all optic pathway gliomas in NF1 patients mani- can occur without associated increased mortality, fest before the age of 6 years and females are more in contrast to the poor prognosis so common in commonly affected by a 2:1 ratio (16,17). Of all patients with metastatic high-grade tumors. In patients with an optic pathway glioma, about one- view of these many contradictions, pilocytic astro- third have NF1, and, of all tumors in this region, cytoma qualifies as “the tumor that is the excep- 40%–70% occur in NF1 patients (14,16,18). tion to the rule.” Pilocytic astrocytomas account for 1.5%–3.5% In this article, we use case material from the of all orbital neoplasms and two-thirds of all neo- Thompson Archives of the Department of Radio- plasms of the optic nerve (3). Most optic pathway logic Pathology at the Armed Forces Institute of pilocytic astrocytomas (75%) arise in children less Pathology to illustrate the spectrum of cross-sec- than 12 years old; in addition, the tumor is more tional imaging manifestations of this common likely to arise in the optic nerve in children, tumor and to present a comprehensive summa- whereas it is more commonly located in the optic tion of the history, pertinent clinical findings, chiasm in adolescents and young adults (19,20). pathologic features, histogenesis, and prognosis Involvement of the chiasm and hypothalamus has associated with this tumor. Salient demographic been reported to occur in 25%–60% of patients and imaging features of pilocytic astrocytoma are (11,19,20). Optic pathway gliomas much less listed in the Table. commonly manifest in adult patients without NF1; when they do, these tumors have a dramati- Epidemiologic Characteristics cally different biologic behavior and are regarded Pilocytic astrocytoma is the most common pediat- histologically as anaplastic astrocytoma or glio- ric cerebellar neoplasm and the most common blastoma multiforme (21). pediatric glioma, constituting 85% of all cerebel- lar astrocytomas and 10% of all cerebral astrocy- Clinical Features tomas in this age group (2). Overall, it accounts Clinical presentation of patients with a pilocytic for 0.6%–5.1% of all intracranial neoplasms and astrocytoma varies with its site of origin. Head- 1.7%–7% of all glial tumors (3). ache, vomiting, gait disturbance, blurred vision, Pilocytic astrocytoma occurs most commonly diplopia, and neck pain are common symptoms in in children and young adults, with most cases patients with a cerebellar pilocytic astrocytoma (75%) manifesting in the first 2 decades of life (22–24). Clinical signs usually include hydro- (2,4). No gender predilection is reported (2). cephalus, papilledema, truncal ataxia, appendicu- lar dysmetria, head tilt, sixth nerve palsy, and nys- tagmus (22,24). RG f Volume 24 ● Number 6 Koeller and Rushing 1695 Characteristics of Pilocytic Astrocytoma Feature Characteristic Manifestation Prevalence Most common (85%) pediatric cerebellar neoplasm and most common pediatric glioma; constitutes 10% of all childhood intracranial neoplasms, 0.6%–5% of all in- tracranial tumors, and 1.7%–7% of all gliomas Age Most patients present before 20 years of age; about 25% are older than 18 years at time of presentation Gender No predominance Location Cerebellum, brainstem, optic nerve and optic chiasm, hypothalamus/thalamus most common; cerebral hemisphere, ventricles, and spinal cord less common; in adults, more common in cerebral hemisphere RadioGraphics Clinical symptoms Dependent on location; typically long duration; tumors in the cerebellum manifest with and signs headache, vomiting, gait disturbance, blurred vision, papilledema, truncal ataxia Special features Association with neurofibromatosis type 1, especially for tumors located in the optic pathway Histologic features Reactive astrocytes with biphasic morphology (loose glial component and compact pi- loid regions), eosinophilic granular bodies (“protein droplets”), Rosenthal fibers; pi- lomyxoid subtype has affinity for hypothalamic region CT appearance Hypoattenuated cystlike component combined with isoattenuated soft-tissue mural nodule MR imaging ap- On T1-weighted images, intense to hypointense; on T2-weighted images, hyperintense pearance (cystic portion), mixed signal (soft-tissue portion); mural nodule shows intense en- hancement; other patterns: ringlike enhancement of cysts, solid near homogeneous enhancement, necrosis with central nonenhancing
Load more

Recommended publications
  • Neurofibromatosis Type 2 (NF2)
    International Journal of Molecular Sciences Review Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis Suha Bachir 1,† , Sanjit Shah 2,† , Scott Shapiro 3,†, Abigail Koehler 4, Abdelkader Mahammedi 5 , Ravi N. Samy 3, Mario Zuccarello 2, Elizabeth Schorry 1 and Soma Sengupta 4,* 1 Department of Genetics, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA; [email protected] (S.B.); [email protected] (E.S.) 2 Department of Neurosurgery, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] (S.S.); [email protected] (M.Z.) 3 Department of Otolaryngology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] (S.S.); [email protected] (R.N.S.) 4 Department of Neurology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] 5 Department of Radiology, University of Cincinnati, Cincinnati, OH 45267, USA; [email protected] * Correspondence: [email protected] † These authors contributed equally. Abstract: Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition to vestibular schwannomas. Meningiomas are a common primary brain tumor; many NF2 patients suffer from multiple meningiomas. In NF2, patients have mutations in the NF2 gene, specifically with loss of function in a tumor-suppressor protein that has a number of synonymous names, including: Merlin, Neurofibromin 2, and schwannomin. Merlin is a 70 kDa protein that has 10 different isoforms. The Hippo Tumor Suppressor pathway is regulated upstream by Merlin. This pathway is critical in regulating cell proliferation and apoptosis, characteristics that are important for tumor progression.
    [Show full text]
  • Leptomeningeal Dissemination of Pilocytic Astrocytoma Via Hematoma in a Child
    Neurosurg Focus 13 (1):Clinical Pearl 2, 2002, Click here to return to Table of Contents Leptomeningeal dissemination of pilocytic astrocytoma via hematoma in a child Case report MASARU KANDA, M.D., HIDENOBU TANAKA, M.D., PH.D., SOJI SHINODA, M.D., PH.D., AND TOSHIO MASUZAWA, M.D., PH.D. Department of Surgical Neurology, Jichi Medical School, Tochigi, Japan A case of recurrent pilocytic astrocytoma with leptomeningeal dissemination (LMD) is described. A cerebellar tumor was diagnosed in a 3-year-old boy, in whom resection was performed. When the boy was 6 years of age, recur- rence was treated with surgery and local radiotherapy. At age 13 years, scoliosis was present, but the patient was asymptomatic. Twelve years after initial surgery LMD was demonstrated in the lumbar spinal region without recur- rence of the original tumor. This tumor also was subtotally removed. During the procedure, a hematoma was observed adjacent to the tumor, but the border was clear. Histological examination of the spinal cord tumor showed features sim- ilar to those of the original tumor. There were no tumor cells in the hematoma. The MIB-1 labeling index indicated no malignant change compared with the previous samples. Radiotherapy was performed after the surgery. The importance of early diagnosis and management of scoliosis is emphasized, and the peculiar pattern of dissemination of the pilo- cytic astrocytoma and its treatment are reviewed. KEY WORDS • pilocytic astrocytoma • leptomeningeal dissemination • MIB-1 labeling index • radiation therapy • scoliosis
    [Show full text]
  • Risk Factors for Gliomas and Meningiomas in Males in Los Angeles County1
    [CANCER RESEARCH 49, 6137-6143. November 1, 1989] Risk Factors for Gliomas and Meningiomas in Males in Los Angeles County1 Susan Preston-Martin,2 Wendy Mack, and Brian E. Henderson Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles, California 90033 ABSTRACT views with proxy respondents, we were unable to include a large proportion of otherwise eligible cases because they were deceased or Detailed job histories and information about other suspected risk were too ill or impaired to participate in an interview. The Los Angeles factors were obtained during interviews with 272 men aged 25-69 with a County Cancer Surveillance Program identified the cases (26). All primary brain tumor first diagnosed during 1980-1984 and with 272 diagnoses had been microscopically confirmed. individually matched neighbor controls. Separate analyses were con A total of 478 patients were identified. The hospital and attending ducted for the 202 glioma pairs and the 70 meningioma pairs. Meningi- physician granted us permission to contact 396 (83%) patients. We oma, but not glioma, was related to having a serious head injury 20 or were unable to locate 22 patients, 38 chose not to participate, and 60 more years before diagnosis (odds ratio (OR) = 2.3; 95% confidence were aphasie or too ill to complete the interview. We interviewed 277 interval (CI) = 1.1-5.4), and a clear dose-response effect was observed patients (74% of the 374 patients contacted about the study or 58% of relating meningioma risk to number of serious head injuries (/' for trend the initial 478 patients).
    [Show full text]
  • Information About Mosaic Neurofibromatosis Type 2 (NF2)
    Information about mosaic Neurofibromatosis type 2 (NF2) NF2 occurs because of a mutation (change) in the NF2 gene. When this change is present at the time of conception the changed gene will be present in all the cells of the baby. When this mutation occurs later in the development of the forming embryo, the baby will go on to have a mix of cells: some with the “normal” genetic information and some with the changed information. This mix of cells is called mosaicism. Approximately half the people who have a diagnosis of NF2 have inherited the misprinted NF2 gene change from their mother or father who will also have NF2. They will have that misprinted gene in all the cells of their body. When they have their children, there will be a 1 in 2 chance of passing on NF2 to each child they have. However about half of people with NF2 are the first person in the family to be affected. They have no family history and have not inherited the condition from a parent. When doctors studied this group of patients more closely they noticed certain characteristics. Significantly they observed that fewer children had inherited NF2 than expected some people in this group had relatively mild NF2 NF2 tumours in some patients tended to grow on one side of their body rather than both sides that when a blood sample was tested to identify the NF2 gene, the gene change could not be found in 30-40% of people This lead researchers to conclude that this group of people were most likely to be mosaic for NF2 i.e.
    [Show full text]
  • Central Nervous System
    PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM LOW GRADE GLIOMAS CNS Site Group – Low Grade Gliomas Author: Dr. Norm Laperriere 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND EARLY DETECTION 3 4. DIAGNOSIS AND PATHOLOGY 3 5. MANAGEMENT 4 5.1 MANAGEMENT ALGORITHMS 4 5.2 SURGERY 4 5.3 CHEMOTHERAPY 5 5.4 RADIATION THERAPY 5 6. ONCOLOGY NURSING PRACTICE 6 7. SUPPORTIVE CARE 6 7.1 PATIENT EDUCATION 6 7.2 PSYCHOSOCIAL CARE 6 7.3 SYMPTOM MANAGEMENT 6 7.4 CLINICAL NUTRITION 7 7.5 PALLIATIVE CARE 7 7.6 REHABILITATION 7 8. FOLLOW-UP CARE 7 Last Revision Date – April 2019 2 Low Grade Gliomas 1. Introduction • Grade I gliomas: pilocytic astrocytoma (PA), dysembryoplastic neuroepithelial tumor (DNET), pleomorphic xanthoastrocytoma, (PXA), ganglioglioma • Grade II gliomas: infiltrating astrocytoma, oligodendroglioma, mixed gliomas • annual incidence is approx. 1/100,000 This document is intended for use by members of the Central Nervous System site group of the Princess Margaret Hospital/University Health Network. The guidelines in this document are meant as a guide only, and are not meant to be prescriptive. There exists a multitude of individual factors, prognostic factors and peculiarities in any individual case, and for that reason the ultimate decision as to the management of any individual patient is at the discretion of the staff physician in charge of that particular patient’s care. 2. Prevention • genetic counseling for all NF1 carriers 3. Screening and Early Detection • baseline MRI brain for all newly
    [Show full text]
  • Original Article Outcome of Supratentorial Intraaxial Extra Ventricular Primary Pediatric Brain Tumors
    Original Article Outcome of supratentorial intraaxial extra ventricular primary pediatric brain tumors: A prospective study Mohana Rao Patibandla, Suchanda Bhattacharjee1, Megha S. Uppin2, Aniruddh Kumar Purohit1 Department of Neurosurgery, Krishna Institute of Medical Sciences Secunderabad, Departments of 1Neurosurgery and 2Pathology, Nizam’s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India Address for correspondence: Dr. Mohana Rao Patibandla, Department of Neurosurgery, University of Colorado Denver, 13123, E 16th Ave, Aurora, CO 80045, USA. Email: [email protected] ABSTRACT Introduction: Tumors of the central nervous system (CNS) are the second most frequent malignancy of childhood and the most common solid tumor in this age group. CNS tumors represent approximately 17% of all malignancies in the pediatric age range, including adolescents. Glial neoplasms in children account for up to 60% of supratentorial intraaxial tumors. Their histological distribution and prognostic features differ from that of adults. Aims and Objectives: To study clinical and pathological characteristics, and to analyze the outcome using the Engel’s classification for seizures, Karnofsky’s score during the available follow‑up period of minimum 1 year following the surgical and adjuvant therapy of supratentorial intraaxial extraventricular primary pediatric (SIEPP) brain tumors in children equal or less than 18 years. Materials and Methods: The study design is a prospective study done in NIMS from October 2008 to January 2012. All the patients less than 18 years of age operated for SIEPP brain tumors proven histopathologically were included in the study. All the patients with recurrent or residual primary tumors or secondaries were excluded from the study. Post operative CT or magnetic resonance imaging (MRI) is done following surgery.
    [Show full text]
  • Simultaneous Neurofibroma and Schwannoma of the Sciatic Nerve
    Simultaneous Neurofibroma and Schwannoma of the Sciatic Nerve 1 4 1 1 2 3 1 S. A. Sintzoff, Jr.,I.5 W . 0. Bank, · P. A. Gevenois, C. Matos, J. Noterman, J. Flament-Durand, and J. Struyven Summary: The authors report a case of simultaneously occur­ MR imaging was performed on a 0.5-T system (Gyro­ ring neurofibroma and schwannoma of the sciatic nerve and scan T5, Philips Medical Systems, Eindhoven, The Neth­ discuss the complementary aspects of MR and OS. The Schwan­ erlands) using a wrap-around knee surface coil in order to norna was well-defined and showed distal enhancement on better define the relationships between the tumors and the sonographic evaluation, whereas the neurofibroma was ill-de­ nerve. Each tumor was isointense to the normal nerve on fined; both tumors were hypoechoic. Tl- and T2-weighted MR T1-weighted images and hyperintense to it on proton Images revealed similar signal characteristics of the two tumors, density and T2-weighted images (Fig. 2A-2C). After intra­ but Intense enhancement following administration of gadolin­ venous gadolinium-DTPA injection, the distal mass showed ium-DTPA distinguished the schwannoma from the neurofi­ intense enhancement, conserving a thin hypointense border broma. (Fig. 2D). Physical and neurologic examination, MR of the central nervous system and skeletal radiographs failed to Index terms: Nerves, sciatic; Neuroma; Schwannoma demonstrate any additional lesions, permitting the reason­ able exclusion of neurofibromatosis types 1 and 2. Schwannomas and neurofibromas are com­ Surgical exposure demonstrated the two tumors on the external popliteal nerve (Fig. 3). The distal tumor could be (1, mon peripheral nerve neoplasms 2).
    [Show full text]
  • Charts Chart 1: Benign and Borderline Intracranial and CNS Tumors Chart
    Charts Chart 1: Benign and Borderline Intracranial and CNS Tumors Chart Glial Tumor Neuronal and Neuronal‐ Ependymomas glial Neoplasms Subependymoma Subependymal Giant (9383/1) Cell Astrocytoma(9384/1) Myyppxopapillar y Desmoplastic Infantile Ependymoma Astrocytoma (9412/1) (9394/1) Chart 1: Benign and Borderline Intracranial and CNS Tumors Chart Glial Tumor Neuronal and Neuronal‐ Ependymomas glial Neoplasms Subependymoma Subependymal Giant (9383/1) Cell Astrocytoma(9384/1) Myyppxopapillar y Desmoplastic Infantile Ependymoma Astrocytoma (9412/1) (9394/1) Use this chart to code histology. The tree is arranged Chart Instructions: Neuroepithelial in descending order. Each branch is a histology group, starting at the top (9503) with the least specific terms and descending into more specific terms. Ependymal Embryonal Pineal Choro id plexus Neuronal and mixed Neuroblastic Glial Oligodendroglial tumors tumors tumors tumors neuronal-glial tumors tumors tumors tumors Pineoblastoma Ependymoma, Choroid plexus Olfactory neuroblastoma Oligodendroglioma NOS (9391) (9362) carcinoma Ganglioglioma, anaplastic (9522) NOS (9450) Oligodendroglioma (9390) (9505 Olfactory neurocytoma Ganglioglioma, malignant (()9521) anaplastic (()9451) Anasplastic ependymoma (9505) Olfactory neuroepithlioma Oligodendroblastoma (9392) (9523) (9460) Papillary ependymoma (9393) Glioma, NOS (9380) Supratentorial primitive Atypical EdEpendymo bltblastoma MdllMedulloep ithliithelioma Medulloblastoma neuroectodermal tumor tetratoid/rhabdoid (9392) (9501) (9470) (PNET) (9473) tumor
    [Show full text]
  • Central Nervous System Tumors General ~1% of Tumors in Adults, but ~25% of Malignancies in Children (Only 2Nd to Leukemia)
    Last updated: 3/4/2021 Prepared by Kurt Schaberg Central Nervous System Tumors General ~1% of tumors in adults, but ~25% of malignancies in children (only 2nd to leukemia). Significant increase in incidence in primary brain tumors in elderly. Metastases to the brain far outnumber primary CNS tumors→ multiple cerebral tumors. One can develop a very good DDX by just location, age, and imaging. Differential Diagnosis by clinical information: Location Pediatric/Young Adult Older Adult Cerebral/ Ganglioglioma, DNET, PXA, Glioblastoma Multiforme (GBM) Supratentorial Ependymoma, AT/RT Infiltrating Astrocytoma (grades II-III), CNS Embryonal Neoplasms Oligodendroglioma, Metastases, Lymphoma, Infection Cerebellar/ PA, Medulloblastoma, Ependymoma, Metastases, Hemangioblastoma, Infratentorial/ Choroid plexus papilloma, AT/RT Choroid plexus papilloma, Subependymoma Fourth ventricle Brainstem PA, DMG Astrocytoma, Glioblastoma, DMG, Metastases Spinal cord Ependymoma, PA, DMG, MPE, Drop Ependymoma, Astrocytoma, DMG, MPE (filum), (intramedullary) metastases Paraganglioma (filum), Spinal cord Meningioma, Schwannoma, Schwannoma, Meningioma, (extramedullary) Metastases, Melanocytoma/melanoma Melanocytoma/melanoma, MPNST Spinal cord Bone tumor, Meningioma, Abscess, Herniated disk, Lymphoma, Abscess, (extradural) Vascular malformation, Metastases, Extra-axial/Dural/ Leukemia/lymphoma, Ewing Sarcoma, Meningioma, SFT, Metastases, Lymphoma, Leptomeningeal Rhabdomyosarcoma, Disseminated medulloblastoma, DLGNT, Sellar/infundibular Pituitary adenoma, Pituitary adenoma,
    [Show full text]
  • Differentiation Between Pilocytic Astrocytoma and Glioblastoma: a Decision Tree Model Using Contrast-Enhanced Magnetic Resonance
    European Radiology (2019) 29:3968–3975 https://doi.org/10.1007/s00330-018-5706-6 ONCOLOGY Differentiation between pilocytic astrocytoma and glioblastoma: a decision tree model using contrast-enhanced magnetic resonance imaging-derived quantitative radiomic features Fei Dong1 & Qian Li1 & Duo Xu1 & Wenji Xiu2 & Qiang Zeng3 & Xiuliang Zhu1 & Fangfang Xu1 & Biao Jiang1 & Minming Zhang1 Received: 13 March 2018 /Revised: 8 July 2018 /Accepted: 6 August 2018 /Published online: 12 November 2018 # European Society of Radiology 2018 Abstract Objective To differentiate brain pilocytic astrocytoma (PA) from glioblastoma (GBM) using contrast-enhanced mag- netic resonance imaging (MRI) quantitative radiomic features by a decision tree model. Methods Sixty-six patients from two centres (PA, n = 31; GBM, n = 35) were randomly divided into training and validation data sets (about 2:1). Quantitative radiomic features of the tumours were extracted from contrast-enhanced MR images. A subset of features was selected by feature stability and Boruta algorithm. The selected features were used to build a decision tree model. Predictive accuracy, sensitivity and specificity were used to assess model performance. The classification outcome of the model was combined with tumour location, age and gender features, and multivariable logistic regression analysis and permutation test using the entire data set were performed to further evaluate the decision tree model. Results A total of 271 radiomic features were successfully extracted for each tumour. Twelve features were selected as input variables to build the decision tree model. Two features S(1, -1) Entropy and S(2, -2) SumAverg were finally included in the model. The model showed an accuracy, sensitivity and specificity of 0.87, 0.90 and 0.83 for the training data set and 0.86, 0.80 and 0.91 for the validation data set.
    [Show full text]
  • Malignant CNS Solid Tumor Rules
    Malignant CNS and Peripheral Nerves Equivalent Terms and Definitions C470-C479, C700, C701, C709, C710-C719, C720-C725, C728, C729, C751-C753 (Excludes lymphoma and leukemia M9590 – M9992 and Kaposi sarcoma M9140) Introduction Note 1: This section includes the following primary sites: Peripheral nerves C470-C479; cerebral meninges C700; spinal meninges C701; meninges NOS C709; brain C710-C719; spinal cord C720; cauda equina C721; olfactory nerve C722; optic nerve C723; acoustic nerve C724; cranial nerve NOS C725; overlapping lesion of brain and central nervous system C728; nervous system NOS C729; pituitary gland C751; craniopharyngeal duct C752; pineal gland C753. Note 2: Non-malignant intracranial and CNS tumors have a separate set of rules. Note 3: 2007 MPH Rules and 2018 Solid Tumor Rules are used based on date of diagnosis. • Tumors diagnosed 01/01/2007 through 12/31/2017: Use 2007 MPH Rules • Tumors diagnosed 01/01/2018 and later: Use 2018 Solid Tumor Rules • The original tumor diagnosed before 1/1/2018 and a subsequent tumor diagnosed 1/1/2018 or later in the same primary site: Use the 2018 Solid Tumor Rules. Note 4: There must be a histologic, cytologic, radiographic, or clinical diagnosis of a malignant neoplasm /3. Note 5: Tumors from a number of primary sites metastasize to the brain. Do not use these rules for tumors described as metastases; report metastatic tumors using the rules for that primary site. Note 6: Pilocytic astrocytoma/juvenile pilocytic astrocytoma is reportable in North America as a malignant neoplasm 9421/3. • See the Non-malignant CNS Rules when the primary site is optic nerve and the diagnosis is either optic glioma or pilocytic astrocytoma.
    [Show full text]
  • (Acoustic Neuroma) After Stereotactic Radiosurgery
    Otology & Neurotology 24:650–660 © 2003, Otology & Neurotology, Inc. Clinical and Histopathologic Features of Recurrent Vestibular Schwannoma (Acoustic Neuroma) after Stereotactic Radiosurgery *Daniel J. Lee, *†William H. Westra, ‡Hinrich Staecker, §Donlin Long, and *John K. Niparko Departments of *Otolaryngology-Head and Neck Surgery, †Pathology, and §Neurologic Surgery, The Johns Hopkins School of Medicine; and ‡Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, University of Maryland Medicine, Baltimore, Maryland, U.S.A. Objective: Stereotactic radiosurgery for vestibular schwan- the cerebellopontine angle and internal auditory canal. Fibrosis noma entails uncertain long-term risk of tumor recurrence and outside and within the tumor bed varied markedly, complicat- delayed cranial neuropathies. In addition, the underlying histo- ing microsurgical dissection. Light microscopy confirmed the pathologic changes to the tumor bed are not fully characterized. presence of viable tumor in all cases. Histopathologic features We seek to understand the clinical and histologic features of were typical of vestibular schwannoma, and there was no sig- recurrent vestibular schwannoma after stereotactic radiation nificant scarring that could be attributed to radiation effect. therapy. Conclusions: The variable fibrosis in the cerebellopontine Study Design: Retrospective review. angle and lack of radiation changes seen histopathologically in Setting: Tertiary referral center. irradiated vestibular schwannoma suggest that a uniform
    [Show full text]